THE golden age of America begins right now,” intoned US President Donald Trump at the start of his inaugural address on Jan ...

The golden age of America begins right now," intoned Donald Trump at the start of his inaugural address on January 20th. The ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...

Despite the broader market downturn, 10 individual stocks showed a strong performance during the trading session, with three ...

A survey of members of the Bioindustry Innovation Organization (BIO) has exposed what is at stake for the sector, on both sides of the Atlantic, if proposed tariffs are imposed on pharmaceutical ...

Bristol Myers Squibb in an all-cash deal at $5 per share, with the merger set to close in Q2 2025. Despite Abecma generating $242 million in U.S. sales, 2seventy still booked a $3.3 million loss from ...

CAMBRIDGE, Mass., March 25, 2025--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights ...

Hillstar Bio has successfully closed a $67 million series A financing round to support its development of next-generation precision immunology therapies for autoimmune diseases. The company’s approach ...

The S&P 500 jumped 2.1% on Friday, March 14, wrapping up a volatile week as government shutdown concerns eased.

根据最新的SEC文件显示，Kynam Capital Management, LP及其关联实体已出售其在2seventy bio, Inc.（NASDAQ:TSVT）的大量股份。该公司以每股USD 4.93的价格出售了16,238,047股股票，总价值约USD 8005万。此次交易后，相关申报实体不再持有该公司任何股份。值得注意的是，TSVT股价在过去一周上涨了73%，根据 ...